OMX Stockholm PI (OMXSPI) moved more or less horizontally on mardi and closed at 982 points (-0.0 percent). 354 shares showed a gain and 543 showed a loss. 88 shares were unchanged and closed at the same price as the previous day. There was no trading in 69 shares. Total value of the trading volume for shares and primary capital certificates mardi was approximately 16.1 billion. | |
AstraZeneca (AZN) closed at 1412 kronor after a steep drop of 7.8 percent. We must go back to juillet 3. 2023 to find an equally steep drop. That time l'action lost 7.9 percent. It was also high volume. Overall it was traded for 1286 millions kronor in l'action, which is five times as much as normal daily turnover. Nor technically does it look good. L'action is trend wise positive in the medium term, but has marginally broken down through the support at 1420 kronor.
Evolution (EVO) declined slightly 0.5 percent and ended the day at 995 kronor. L'action has now closed down for the eighth day in a row. L'action is trend wise negative in the medium term.
Saniona (SANION) ended with a solid gain of 34.4 percent and closed at 5.18 kronor. We must go back to mars 3. 2023 to find an equally strong rise. That time l'action gained 41.2 percent. It was also very high volume. Overall it was traded for 22 millions kronor in l'action, which is 20 times as much as normal daily turnover. Technically it also looks good. L'action is trend wise positive in the medium term and a further increase is indicated.
Revolutionrace (RVRC) closed at 39.52 kronor after a steep drop of 16.2 percent. We must go back to août 16. 2022 to find an equally steep drop. That time l'action lost 34.5 percent. It was also very high volume. Overall it was traded for 88 millions kronor in l'action, which is 14 times as much as normal daily turnover. Nor technically does it look good. L'action is trend wise negative in the medium term, has broken down through the support at 42.00 kronor and a further decline is indicated.
Nobia (NOBI) closed at 4.40 kronor after posting a loss of 14.4 percent. L'action has never lost more in one day since février 20, when it was down 28.0 percent. L'action broke down through the support at 4.95 kronor in formation tête-épaules. This triggered a sell signal on increasing volume and a further drop to 3.95 kronor within four months is indicated. It was also very high volume. Overall it was traded for 48 millions kronor in l'action, which is 11 times as much as normal daily turnover.
|
Saniona | 34.37% |
Sedana Medical | 9.04% |
Idun Industrier B | 6.79% |
Moberg Pharma | 6.64% |
LumenRadio | 6.55% |
Revolutionrace | -16.20% |
Boozt | -14.99% |
Nobia | -14.40% |
Diagonal Bio | -10.48% |
AstraZeneca | -7.77% |
AstraZeneca | 1286.45 |
Volvo B | 686.04 |
Investor B | 537.26 |
Nordea Bank | 474.45 |
Ericsson B | 453.89 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.